GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

GMED · Sep 30, 2025

GLOBUS MEDICAL INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001237831-25-000031General Corporate
Capex intensity25thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

4.66% · OPTIONAL · VALID

Operating cash generation88thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

32.47% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

22.91% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure25thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

100.32% · OPTIONAL · VALID

Operating margin100thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

17.86% · CORE · VALID

R&D intensity0thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

4.95% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.50% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
6.25%
Current
4.66%
Delta
-1.59%
Cash Generation Increased
Previous
10.45%
Current
32.47%
Delta
22.02%
Growth Increased
Previous
18.37%
Current
22.91%
Delta
4.54%
Inventory Pressure Decreased
Previous
103.59%
Current
100.32%
Delta
-3.27%
Profitability Increased
Previous
10.21%
Current
17.86%
Delta
7.65%
R And D Intensity Decreased
Previous
5.36%
Current
4.95%
Delta
-0.41%
Sbc Intensity Decreased
Previous
1.83%
Current
1.50%
Delta
-0.33%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · GMED Fundamental State →Has State · GLOBUS MEDICAL INC →Transitioned To · GMED Fundamental State →Transitioned To · GMED CAPEX_INTENSITY_DECREASED →Transitioned To · GMED CASH_GENERATION_INCREASED →Transitioned To · GMED GROWTH_INCREASED →Transitioned To · GMED INVENTORY_PRESSURE_DECREASED →Transitioned To · GMED PROFITABILITY_INCREASED →Transitioned To · GMED R_AND_D_INTENSITY_DECREASED →Transitioned To · GMED SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.